Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 10/2013

01.10.2013 | Letter to the Editor

Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting

verfasst von: Sandip Basu, Purushottam Kand, Madhav Mallia, Aruna Korde, Hemant Shimpi

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …
Literatur
1.
Zurück zum Zitat Guggenberg EV, Mikolajczak R, Janota B, Riccabona G, Decristoforo C. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]-octreotide, a somatostatin analog for tumor diagnosis. J Pharm Sci. 2004;93(10):2497–506.PubMedCrossRef Guggenberg EV, Mikolajczak R, Janota B, Riccabona G, Decristoforo C. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]-octreotide, a somatostatin analog for tumor diagnosis. J Pharm Sci. 2004;93(10):2497–506.PubMedCrossRef
Metadaten
Titel
Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting
verfasst von
Sandip Basu
Purushottam Kand
Madhav Mallia
Aruna Korde
Hemant Shimpi
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 10/2013
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-013-2501-0

Weitere Artikel der Ausgabe 10/2013

European Journal of Nuclear Medicine and Molecular Imaging 10/2013 Zur Ausgabe